Pharma Markets

Europe Neuroblastoma Market and Competitive Landscape

By Fore Pharma | Published Date: June 7, 2020 | On-Demand Data

The latest research from Fore Pharma, Europe Neuroblastoma Market and Competitive Landscape – 2020, provides comprehensive insights into Neuroblastoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Neuroblastoma market size and drug sales. It also provides insights into Neuroblastoma epidemiology and late stage pipeline.

This research covers the following – Neuroblastoma treatment options, Neuroblastoma late stage clinical trials pipeline, Neuroblastoma prevalence by countries, Neuroblastoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

– Countries: Germany, France, Italy, Spain, UK, Europe
– Neuroblastoma pipeline: Find out drugs in clinical trials for Neuroblastoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Neuroblastoma epidemiology: Find out number of patients diagnosed (prevalence) with Neuroblastoma by countries
– Neuroblastoma drugs: Identify key drugs marketed and prescribed for Neuroblastoma by countries, including trade name, molecule name, and company
– Neuroblastoma drugs sales: Find out the sales value for Neuroblastoma drugs by countries
– Neuroblastoma market valuations: Find out the market size for Neuroblastoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Neuroblastoma drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research: The research helps executives to

– Evaluate commercial market opportunities for Neuroblastoma drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Neuroblastoma market
– Develop in-depth knowledge of competition and markets
– Analyze Neuroblastoma drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Neuroblastoma market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents


1. Neuroblastoma Treatment Options
2. Neuroblastoma Pipeline Insights
2.1. Neuroblastoma Phase 3 Clinical Trials
2.2. Neuroblastoma Phase 2 Clinical Trials
2.3. Neuroblastoma Phase 1 Clinical Trials
3. Neuroblastoma Epidemiology Analysis by Countries
4. Germany Neuroblastoma Market Insights
4.1. Marketed Drugs for Neuroblastoma in Germany
4.2. Germany Neuroblastoma Market Size & Forecast
4.3. Germany Neuroblastoma Drugs Sales Forecast
4.4. Germany Neuroblastoma Market Share Analysis
5. France Neuroblastoma Market Insights
5.1. Marketed Drugs for Neuroblastoma in France
5.2. France Neuroblastoma Market Size & Forecast
5.3. France Neuroblastoma Product Sales Forecast
5.4. France Neuroblastoma Market Share Analysis
6. Italy Neuroblastoma Market Insights
6.1. Marketed Drugs for Neuroblastoma in Italy
6.2. Italy Neuroblastoma Market Size & Forecast
6.3. Italy Neuroblastoma Product Sales Forecast
6.4. Italy Neuroblastoma Market Share Analysis
7. Spain Neuroblastoma Market Insights
7.1. Marketed Drugs for Neuroblastoma in Spain
7.2. Spain Neuroblastoma Market Size & Forecast
7.3. Spain Neuroblastoma Product Sales Forecast
7.4. Spain Neuroblastoma Market Share Analysis
8. UK Neuroblastoma Market Insights
8.1. Marketed Drugs for Neuroblastoma in UK
8.2. UK Neuroblastoma Market Size & Forecast
8.3. UK Neuroblastoma Product Sales Forecast
8.4. UK Neuroblastoma Market Share Analysis
9. Europe Neuroblastoma Market Insights
9.1. Europe Neuroblastoma Market Size & Forecast
9.2. Europe Neuroblastoma Product Sales Forecast
9.3. Europe Neuroblastoma Market Share Analysis
10. Research Methodology

List of Tables


1: Neuroblastoma Phase 3 Clinical Trials, Global, 2020
2: Neuroblastoma Phase 2 Clinical Trials, Global, 2020
3: Neuroblastoma Phase 1 Clinical Trials, Global, 2020
4: Neuroblastoma Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Neuroblastoma in Germany, 2019
6: Germany Neuroblastoma Market Size & Forecast ($mn), 2016 – 2025
7: Germany Neuroblastoma Product Sales ($mn), 2016 – 2025
8: Germany Neuroblastoma Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Neuroblastoma in France, 2019
10: France Neuroblastoma Market Size & Forecast ($mn), 2016 – 2025
11: France Neuroblastoma Product Sales ($mn), 2016 – 2025
12: France Neuroblastoma Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Neuroblastoma in Italy, 2019
14: Italy Neuroblastoma Market Size & Forecast ($mn), 2016 – 2025
15: Italy Neuroblastoma Product Sales ($mn), 2016 – 2025
16: Italy Neuroblastoma Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Neuroblastoma in Spain, 2019
18: Spain Neuroblastoma Market Size & Forecast ($mn), 2016 – 2025
19: Spain Neuroblastoma Product Sales ($mn), 2016 – 2025
20: Spain Neuroblastoma Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Neuroblastoma in UK, 2019
22: UK Neuroblastoma Market Size & Forecast ($mn), 2016 – 2025
23: UK Neuroblastoma Product Sales ($mn), 2016 – 2025
24: UK Neuroblastoma Market Events and Trends, 2016 – 2025
25: Europe Neuroblastoma Market Size & Forecast ($mn), 2016 – 2025
26: Europe Neuroblastoma Product Sales ($mn), 2016 – 2025

List of Figures


1: Neuroblastoma Pipeline by Phase (%), Global, 2020
2: Neuroblastoma Prevalence by Countries, 2016 – 2025
3: Germany Neuroblastoma Market Size ($mn), 2016 – 2025
4: Germany Neuroblastoma Product Sales ($mn), 2016 – 2025
5: Germany Neuroblastoma Market Share by Drugs (%), 2019
6: Germany Neuroblastoma Market – Future Market Share (%), 2025
7: France Neuroblastoma Market Size ($mn), 2016 – 2025
8: France Neuroblastoma Product Sales ($mn), 2016 – 2025
9: France Neuroblastoma Market Share by Drugs (%), 2019
10: France Neuroblastoma Market – Future Market Share (%), 2025
11: Italy Neuroblastoma Market Size ($mn), 2016 – 2025
12: Italy Neuroblastoma Product Sales ($mn), 2016 – 2025
13: Italy Neuroblastoma Market Share by Drugs (%), 2019
14: Italy Neuroblastoma Market – Future Market Share (%), 2025
15: Spain Neuroblastoma Market Size ($mn), 2016 – 2025
16: Spain Neuroblastoma Product Sales ($mn), 2016 – 2025
17: Spain Neuroblastoma Market Share by Drugs (%), 2019
18: Spain Neuroblastoma Market – Future Market Share (%), 2025
19: UK Neuroblastoma Market Size ($mn), 2016 – 2025
20: UK Neuroblastoma Product Sales ($mn), 2016 – 2025
21: UK Neuroblastoma Market Share by Drugs (%), 2019
22: UK Neuroblastoma Market – Future Market Share (%), 2025
23: Europe Neuroblastoma Market Size ($mn), 2016 – 2025
24: Europe Neuroblastoma Product Sales ($mn), 2016 – 2025
25: Europe Neuroblastoma Market Share by Drugs (%), 2019
26: Europe Neuroblastoma Market – Future Market Share (%), 2025

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies